Search - tctmd.com

Displaying 61 - 80 of 1179

Sort: Relevancy | Date

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Caitlin E. Cox

July 11, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Risk of Death Remains Low a Decade After Primary PCI for STEMI

Caitlin E. Cox

June 18, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

Advertisement

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Risk of Death Remains Low a Decade After Primary PCI for STEMI

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content